These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 31083399)

  • 1. Inflammatory and Molecular Pathways in Heart Failure-Ischemia, HFpEF and Transthyretin Cardiac Amyloidosis.
    Michels da Silva D; Langer H; Graf T
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31083399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transthyretin cardiac amyloidosis: pathogenesis, treatments, and emerging role in heart failure with preserved ejection fraction.
    Ton VK; Mukherjee M; Judge DP
    Clin Med Insights Cardiol; 2014; 8(Suppl 1):39-44. PubMed ID: 25628512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Phenotyping of Transthyretin Cardiac Amyloidosis with Bone-Seeking Radiotracers in Heart Failure with Preserved Ejection Fraction.
    Chen W; Ton VK; Dilsizian V
    Curr Cardiol Rep; 2018 Mar; 20(4):23. PubMed ID: 29520480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart Failure Complicated by Alveolar Hemorrhage due to Vascular Collapse and Amyloid Deposits in Wild-Type Transthyretin Amyloidosis.
    Kido Y; Takahashi M; Fukuma N; Kawata T; Tanaka A; Hayashi A; Shibahara J; Daimon M; Morita H; Akazawa H; Komuro I
    Cardiology; 2016; 135(4):216-220. PubMed ID: 27522614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart failure with preserved ejection fraction, atrial fibrillation, and the role of senile amyloidosis.
    van den Berg MP; Mulder BA; Klaassen SHC; Maass AH; van Veldhuisen DJ; van der Meer P; Nienhuis HLA; Hazenberg BPC; Rienstra M
    Eur Heart J; 2019 Apr; 40(16):1287-1293. PubMed ID: 30753432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New and Evolving Concepts Regarding the Prognosis and Treatment of Cardiac Amyloidosis.
    Perlini S; Mussinelli R; Salinaro F
    Curr Heart Fail Rep; 2016 Dec; 13(6):267-272. PubMed ID: 27900617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction.
    González-López E; Gallego-Delgado M; Guzzo-Merello G; de Haro-Del Moral FJ; Cobo-Marcos M; Robles C; Bornstein B; Salas C; Lara-Pezzi E; Alonso-Pulpon L; Garcia-Pavia P
    Eur Heart J; 2015 Oct; 36(38):2585-94. PubMed ID: 26224076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolated heart transplantation for familial transthyretin (TTR) V122I cardiac amyloidosis.
    Thenappan T; Fedson S; Rich J; Murks C; Husain A; Pogoriler J; Anderson AS
    Amyloid; 2014 Jun; 21(2):120-3. PubMed ID: 24818650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of clinical characteristics of cardiac amyloidosis as a potential underlying etiology in patients diagnosed with heart failure with preserved ejection fraction.
    Murat S; Cavusoglu Y; Yalvac HE; Sivrikoz IA; Kocagil S
    Kardiol Pol; 2022; 80(6):672-678. PubMed ID: 35390167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of heart failure with reduced ejection fraction in patients with transthyretin cardiac amyloidosis.
    Asif T; Araujo T; Singh V; Malhotra S
    J Nucl Cardiol; 2020 Jun; 27(3):1044-1046. PubMed ID: 32185683
    [No Abstract]   [Full Text] [Related]  

  • 11. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
    Paulus WJ; Tschöpe C
    J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wild type transthyretin cardiac amiloidozis as a rare and overlooked underlying etiology in a patient with heart failure with preserved ejection fraction and left ventricular hypertrophy.
    Murat S; Çavuşoğlu Y; Ak Sivrikoz İ
    Turk Kardiyol Dern Ars; 2021 Oct; 49(7):579-584. PubMed ID: 34623301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac Transthyretin-derived Amyloidosis: An Emerging Target in Heart Failure with Preserved Ejection Fraction?
    Klaassen SH; van Veldhuisen DJ; Nienhuis H; van den Berg MP; Hazenberg BP; van der Meer P
    Card Fail Rev; 2020 Mar; 6():e21. PubMed ID: 32944291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarker Profiles in Heart Failure Patients With Preserved and Reduced Ejection Fraction.
    Tromp J; Khan MA; Klip IT; Meyer S; de Boer RA; Jaarsma T; Hillege H; van Veldhuisen DJ; van der Meer P; Voors AA
    J Am Heart Assoc; 2017 Mar; 6(4):. PubMed ID: 28360225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarker Profiles of Acute Heart Failure Patients With a Mid-Range Ejection Fraction.
    Tromp J; Khan MAF; Mentz RJ; O'Connor CM; Metra M; Dittrich HC; Ponikowski P; Teerlink JR; Cotter G; Davison B; Cleland JGF; Givertz MM; Bloomfield DM; Van Veldhuisen DJ; Hillege HL; Voors AA; van der Meer P
    JACC Heart Fail; 2017 Jul; 5(7):507-517. PubMed ID: 28624483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis.
    Quarta CC; Solomon SD; Uraizee I; Kruger J; Longhi S; Ferlito M; Gagliardi C; Milandri A; Rapezzi C; Falk RH
    Circulation; 2014 May; 129(18):1840-9. PubMed ID: 24563469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation in HFpEF: Key or circumstantial?
    van Empel V; Brunner-La Rocca HP
    Int J Cardiol; 2015; 189():259-63. PubMed ID: 25897922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TTR (Transthyretin) Stabilizers Are Associated With Improved Survival in Patients With TTR Cardiac Amyloidosis.
    Rosenblum H; Castano A; Alvarez J; Goldsmith J; Helmke S; Maurer MS
    Circ Heart Fail; 2018 Apr; 11(4):e004769. PubMed ID: 29615436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of prognostic markers in transthyretin and AL cardiac amyloidosis.
    Damy T; Jaccard A; Guellich A; Lavergne D; Galat A; Deux JF; Hittinger L; Dupuis J; Frenkel V; Rigaud C; Plante-Bordeneuve V; Bodez D; Mohty D
    Amyloid; 2016 Sep; 23(3):194-202. PubMed ID: 27647161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac amyloidosis: a review and report of a new transthyretin (prealbumin) variant.
    Hesse A; Altland K; Linke RP; Almeida MR; Saraiva MJ; Steinmetz A; Maisch B
    Br Heart J; 1993 Aug; 70(2):111-5. PubMed ID: 8038017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.